NCT07388992

Brief Summary

The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
1mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Mar 2026Jun 2026

First Submitted

Initial submission to the registry

January 28, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 5, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

March 16, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

January 28, 2026

Last Update Submit

March 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • description of ambulation pattern in controlled environment in people living with multiple sclerosis (pwMS) with different disease severities

    Measurement of daily life-like activity movements by Optical Motion Capture, pressure sensitive walkway and wearable sensors

    enrollment

Study Arms (2)

people living with Multiple Sclerosis

Healthy Adult

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with MS will be recruited from the CHU Lille. Patients will be informed of this study by the Investigator during routine follow-up visits. The Investigator will also connect with local patient organizations and share a flyer. This flyer will also be displayed within the Neurology and Neurological Rehabilitation departments of the hospital and diffused to the hospital staff.

You may qualify if:

  • For people living with multiple sclerosis (pwMS):
  • Signed informed consent and ability to comply with study and follow-up.
  • Confirmed MS diagnosis according to McDonald criteria (2017)
  • Expanded Disability Status Scale EDSS = 6
  • Ability and willingness to participate in and comply with all study procedures defined in the protocol
  • Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category
  • For Healthy volunteers :
  • Signed informed consent and ability to comply with study and follow-up.
  • Ability and willingness to participate in and comply with all study procedures defined in the protocol
  • Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category

You may not qualify if:

  • For pwMS:
  • Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
  • Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
  • Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
  • For healthy volunteers (HV):
  • Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
  • Past or present pathology or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
  • Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Lille

Lille, France

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Patrick Vermersch

    CHU Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2026

First Posted

February 5, 2026

Study Start

March 16, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 23, 2026

Record last verified: 2026-03

Locations